Based on the 3D structure of the WW domain of human Yes-associated protein (hYAP-WW) in complex with a proline-rich peptide ligand, we have designed and synthesized a cyclic peptide covering a fragment of hYAP-WW that contains its primary contact residues for the interaction with the ligand. This peptide was found to specifically recognize a proline-rich ligand for hYAP-WW. Its conformation was calculated using molecular dynamics simulation, based on long-range NOEs identified by NMR spectroscopy, and indicates an arrangement of primary contact residues similar to hYAP-WW.
INTRODUCTION
Specific interactions between proteins and their ligands are the molecular basis of essentially all biological processes. The exploration of these interactions at the molecular and atomic level is an important step towards the modulation of protein function through controlled interference with the underlying binding events. The design and generation of molecules capable of mimicking conformationally defined binding and/or functional sites of natural proteins, represents a promising strategy for the exploration and understanding of protein structure and function. Such proteinmimetics are also useful tools for a range of biomedical applications, including the inhibition of protein-ligand interactions (Eichler, 2005) .
WW domains, which owe their name to the presence of two highly conserved tryptophan residues in their sequences, are relatively short (35-45 amino acid residues) protein interaction domains in various signaling and regulatory proteins, which are involved in signaling pathways underlying several human diseases (Chen and Sudol, 1995) . Similar to SH3 (Yu et al., 1994) , EVH1 (Niebuhr et al., 1997) and GYF (Nishizawa et al., 1998) domains, WW domains recognize proline-rich ligand motifs in other proteins (Kay et al., 2000; Ball et al., 2005) . NMR analysis of complexes of the WW domain of human Yes-associated protein (hYAP-WW) with proline-rich peptide ligands revealed that the ligand binding site of hYAP-WW is located within the b2 and b3 strands of a three-stranded antiparallel bsheet in the C-terminal part of the protein (Fig. 1 ) (Macias et al., 1996; Pires et al., 2001) . The side chains of hydrophobic residues within this sequence stretch (Y28, L30 and W39) form a hydrophobic patch on the protein surface, and constitute, along with H32, the primary contact residues of hYAP-WW for its interaction with proline-rich ligands. The importance of these residues for the interaction with the ligand was also confirmed using arrays of synthetic hYAP-WW variants, which addressed each position of the protein sequence individually (Toepert et al., , 2003 .
As part of our ongoing efforts aimed at mimicking conformationally defined protein binding sites (Eichler, 2004; Hunke et al., 2006; Franke et al., 2007) , the goal of this study was to mimic the binding site of hYAP-WW by a synthetic peptide presenting a fragment (27-40) of the protein, which covers two strands of the b-sheet that contain the primary contact residues (Y28, L30, H32 and W39). In order to assess the influence of a conformational constraint on the binding behaviour of this peptide, it was synthesized in cyclic, as well as in linear shape.
MATERIALS AND METHODS

Peptide Synthesis
Peptides (see Table I for sequences) were synthesized by automated solid-phase synthesis, as previously described (Franke et al., 2004) . Briefly, peptides were generated as C-terminal amides on polyoxyethylene-grafted polystyrene resin, to which the Rink amide linker was attached (TentaGel S RAM resin). Fmoc-amino acids were coupled as HOBt esters (5 eq., 2 Â 1 h), followed by capping with acetic anhydride/pyridine/DMF (1:2:3) for 15 min. In WWpep, WWpep* and WWpep**, an ivDde-side chain protected lysine residue was added to the C-terminus of the sequence, and the N-terminus was succinylated using 10 eq. of succinic anhydride in 5% DIEA/DMF. After removal of the ivDde group (5% hydrazine in DMF, 7 Â 5 min.), the peptides were cyclized on the resin through amide formation between the succinyl group at the Nterminus and the e-amino group of the C-terminal lysine residue, using 2 eq. PyBOP/HOBt and 4 eq. DIEA (2 Â 4 h). Peptides were cleaved from the resin using a mixture of TFA, DCM, water and triisopropylsilane (70:20:5:5, 2 Â 3 h), precipitated in a cold 1:1 mixture of t-butylmethyl ether and cyclohexane, extracted with water, and lyophilized. Crude peptides were purified by preparative RP-HPLC (Column: Nucleosil RP18, 250 Â 10 mm; flow rate: 3 mL/min; gradient: 5-95% MeCN in H 2 O, both containing 0.1% TFA, in 60 min; UV detection: 220 nm).
NMR Spectroscopy
WWpep** was dissolved at 5 mg/mL in H 2 O/D 2 O, 10:1. Twodimensional 1 H NMR Spectra (COSY, TOCSY, mixing time Fig. 1 . NMR-structure of a complex of the WW domain of human Yes-associated protein (hYAP-WW) with the peptide ligand GTPPPPYTVG (Macias et al., 1996) . The fragment shown in darker shade represents the peptide synthesized to mimic the hYAP-WW binding site (27RYFLNHIDQTTTWQ40), presenting the primary contact residues of hYAP-WW. 
Molecular Dynamics Simulation
Starting from a structurally unbiased cyclic conformation, allatom explicit water simulations of WWpep** were performed using the GROMACS molecular dynamics package (Berendsen et al., 1995; Lindahl et al., 2001) . The system was solvated and equilibrated for 20 ps at 300 K, 1 atm, and then run for 1 ns using NMR-derived constraints to guide the simulation. The following constraints were used: Lys41Hd1-Y28Hb1 (3.4 Å ), Lys41He1-Y28Hb2 (3.2 Å ), Lys41He1-Y28HN (3.8 Å ), Q40Hc1-F29Ha (3.9 Å ) and T37Ha-N31HN (3.9 Å ), in which Lys41 represents the C-terminally added lysine residue used for cyclization via its eamino group.
Binding Assay hYAP-WW, hYAP-WW*, WWpep and WWpep*, respectively (100 lL; 10, 5 and 2.5 lM in phosphate buffer (0.1 M, pH 7.2), were coated in duplicate overnight at 4°C to the wells of a 96-well sulfhydryl binding assay plate (Corning). Unspecific binding was blocked with 1% BSA in phosphate buffer containing 0.01% Tween 20, for one hour, followed by incubation with ligand solution (Biotin-Ahx-EYPPYPPPPYPSG-NH 2 , 100 lL, 15 lM in 0.1% BSA/phosphate buffer containing 0.01% Tween 20) for 90 min. Plate-bound ligand was detected using an anti-biotin-HRP conjugate (1 h, dilution: 1:1000 in phosphate buffer containing 0.01% Tween 20), followed by developing the plate in the dark with 100 lL OPD solution (1 mg/mL in 0.03% H 2 O 2 /water). The reaction was stopped after 10 min. by adding 50 lL 4 N sulfuric acid, and absorbances (ODs) were read at 490 nm using a plate reader (Spectramax 250).
RESULTS AND DISCUSSION
Complete hYAP-WW, a cyclic peptide covering its binding site (WWpep), a linear analog of WWpep, analogs of hYAP-WW and WWpep, in which three of the primary contact residues were replaced by alanine (hYAP-WW* and WWpep*), a truncated analog of WWpep lacking the C-terminal Ahx and cysteine residues (WWpep**), as well as a labeled proline-rich ligand for hYAP-WW, (see Table I for peptide sequences) were synthesized using automated Fmoc/tBu-based solid phase synthesis, and purified by preparative HPLC (Fig. 2) . hYAP-WW and derived peptides were equipped with an additional cysteine residue for site-selective, covalent immobilization on assay plates. The ligand represents residues 742-754 of the p53-binding protein 2 (Naumovski and Cleary, 1996) , and was biotinylated for detection in the binding assay.
Binding affinities to the proline-rich ligand of hYAP-WW, WWpep and its linear analog, as well as hYAP-WW* and WWpep* were compared in a direct binding assay. As shown in Fig. 3 , WWpep retains approximately 20% of the affinity of hYAP-WW, while the linear analog of WWpep has no affinity to the ligand, suggesting that cyclization stabilizes conformations required for binding to the proline-rich ligand, likely by bringing into spatial proximity primary contact residues that are on opposite ends of the sequence of WWpep (Y28 and W39). Furthermore, replacement of three primary contact residues in hYAP-WW (hYAP-WW*), as well as in WWpep (WWpep*), with alanine resulted in complete loss of affinity to the ligand, suggesting a similar binding specificity of the complete domain and the mimetic peptide.
WWpep** was structurally characterized using two-dimensional 1 H NMR spectroscopy. In addition to the NOEs that were expected based on sequential proximity, such as HN(i + 1)-Ha(i), Ha(i + 1)-Ha (i), HN(i + 1)-HN(i), several long-range NOEs between spin systems of sequentially distant amino acids were observed, in particular between the Ca proton of F29 and a Cc proton of Q40, as well as between the amide proton of N31 and the Ca proton of T37 (Fig. 4) . Using these long-range NOEs as constraints, a conformation of WWpep** was calculated by molecular dynamics simulation. Conformations that obey all constraints at various time-intervals during the simulation are in agreement within a heavy atom RMSD of 1.5 Å (Fig. 5, left) . Although the obtained structure does not involve a beta sheet (Fig. 5, right) , the distances between, and arrangement of, the primary contact residues (Y28, L30, W39 and H32) are similar to those in hYAP-WW (Table II) , with the exception of the distance between Y28 and W39, which is almost twice as long in WWpep**. This similarity in presentation of contact residues is likely to be the structural basis of the ability of the mimetic peptide to interact with the proline-rich ligand.
CONCLUDING REMARKS
Based on the 3D structure of a hYAP-WWligand complex, cyclic peptides (WWpep and WWpep**) were generated, which present the hYAP-WW binding site for proline-rich ligands. WWpep was found to interact with a proline-rich ligand for hYAP-WW, while the respective linear peptide had no affinity to the ligand. Furthermore, replacement of three primary contact residues in hYAP-WW and WWpep with alanine resulted in complete loss of affinity to the ligand, indicating a similar binding specificity of both molecules. Based on long-range NOEs detected in NMR spectra of WWpep**, a conformation was modeled using molecular dynamics simulations, in which the primary contact residues are presented in an arrangement similar to hYAP-WW. These results illustrate the applicability of synthetic peptides as functional and structural mimetics of conformationally defined protein binding sites. Ultimately, such synthetic mimics, as well as their substitution analogs, can be used as probes for the understanding of molecular events underlying human diseases. 
